American Journal of Cardiovascular Drugs

Optimizing the Pharmacologic Treatment of Hypertension: BP Control and Target Organ Protection
pp. 287-295(9)
Author: Nilsson, Peter M.

Thiazolidinediones in Patients with Diabetes Mellitus and Heart Failure: Implications of Emerging Data
pp. 297-304(8)
Authors: Macfarlane, David P.; Fisher, Miles

Therapeutic Potential of Thymosin-β4 and its Derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in Cardiac Healing After Infarction
pp. 305-311(7)
Author: Cavasin, Maria A.

Medical Treatment of Patients with Heart Failure or Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention
pp. 313-325(13)
Authors: Lipinski, Michael J.; Vetrovec, George W.

The ASCOT Trial: Clarifying the Role of ACE Inhibition in the Reduction of Cardiovascular Events in Patients with Hypertension
pp. 327-334(8)
Author: Meurin, Philippe

The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study): Rationale and Baseline Characteristics
pp. 335-342(8)
Authors: Smith, Ronald D.; Yokoyama, Hiroshi; Averill, David B.; Cooke, Lori; Brosnihan, K. Bridget; Schiffrin, Ernesto L.; Ferrario, Carlos M.

The Effect of Moxonidine on Endothelial Dysfunction in Metabolic Syndrome
pp. 343-348(6)
Authors: Topal, Ergun; Ayse Sertkaya Cikim,; Cikim, Kerim; Temel, Ismail; Ozdemir, Ramazan

Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study
pp. 349-355(7)
Authors: Alemao, Evo; Yin, Don; Sintonen, Harri; Salomaa, Veikko; Jousilahti, Pekka

Spotlight on Ranolazine in Chronic Stable Angina Pectoris
pp. 357-359(3)
Authors: Siddiqui, M. Asif A.; Keam, Susan J.